investors events & presentations corporate governance financials & filings stock information analyst coverage contact us news press releases in the news programs & pipeline therapeutic focus partnering scientific publications careers current openings benefits and incentives our culture contact flexion therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel local therapies for the treatment of patients with musculoskeletal conditions beginning with osteoarthritis oa a type of degenerative arthritis . the company is currently advancing a drug candidate that has the potential to provide rapid powerful and durable pain relief compared with existing therapies . our lead product candidate zilretta also known as fx006 is a sustained release intra articular non opioid investigational treatment in late stage development for patients with moderate to severe oa pain . press releasesflexion therapeutics announces appointment of john magee as vice president of sales september 29 2016flexion therapeutics announces appointment of mark stejbach to its board of directors september 14 2016flexion therapeutics announces two key corporate appointments september 12 2016 in the newswhy analysts still like flexion s osteoarthritis drug even after big trial miss september 16 2015flexion therapeutics drug trumps saline for oa pain relief september 11 2015biospace . com article flexion flxn ceo discusses pipeline and jobs april 2 2015 featured activitiesflexion therapeutics to present at the 2016 wells fargo healthcare conference wednesday september 7 2016 2 55 pm 3 25 pm register for the webcast view the webcast if already registered view the presentation flexion update on pivotal clinical trial results for zilretta conference call view the webcast pivotal phase 2b and phase 3 results for zilretta fx006 podium presentation osteoarthritis research society international oarsi 2016 world congress view the presentation the netherlands amsterdam april 2 2016 2016 flexion therapeutics info flexiontherapeutics.com 781.305.7777 website design & development by graphic beans terms of use sitemap privacy policy connect with us